Literature DB >> 25893991

Flavonoids mixture (diosmin, troxerutin, hesperidin) in the treatment of acute hemorrhoidal disease: a prospective, randomized, triple-blind, controlled trial.

I Giannini1, A Amato, L Basso, N Tricomi, M Marranci, G Pecorella, S Tafuri, D Pennisi, D F Altomare.   

Abstract

BACKGROUND: The role of a mixture of phlebotonics in the treatment of acute hemorrhoid crisis is investigated to test their efficacy.
METHODS: One hundred and thirty-four consecutive patients with an acute hemorrhoidal crisis recruited in five colorectal units entered the study. Sixty-six of them were randomized to receive a mixture of diosmin, troxerutin and hesperidin (group A), and 68 a placebo (group B). The main symptoms, the use of oral painkillers and the Bristol scale score were recorded at each scheduled visit and compared using both Student's t test for independent samples and the ANOVA models for repeated measures. The presence of edema, prolapse and thrombosis were also recorded and compared using the Chi-square test. Furthermore, the trend of proportions during the time of the evaluations was assessed by the Chi-square test for linear trend.
RESULTS: Pain, bleeding and the proportion of patients who reported persistence of edema and thrombosis decreased significantly after 12 days of treatment in group A. After 6 days, the number of paracetamol tablets taken by patients in group A was significantly lower than the amount of flavonoid mixture.
CONCLUSIONS: The use of a mixture of diosmin, troxerutin and hesperidin is a safe and effective mean of managing symptoms of acute hemorrhoidal disease. Furthermore, in patients receiving treatment, there was faster control and lower persistence of edema and thrombosis.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25893991     DOI: 10.1007/s10151-015-1302-9

Source DB:  PubMed          Journal:  Tech Coloproctol        ISSN: 1123-6337            Impact factor:   3.781


  18 in total

1.  The treatment of hemorrhoids: guidelines of the Italian Society of Colorectal Surgery.

Authors:  D F Altomare; A Roveran; G Pecorella; F Gaj; E Stortini
Journal:  Tech Coloproctol       Date:  2006-09-20       Impact factor: 3.781

2.  Practice parameters for the management of hemorrhoids (revised 2010).

Authors:  David E Rivadeneira; Scott R Steele; Charles Ternent; Sridhar Chalasani; W Donald Buie; Janice L Rafferty
Journal:  Dis Colon Rectum       Date:  2011-09       Impact factor: 4.585

Review 3.  Meta-analysis of flavonoids for the treatment of haemorrhoids.

Authors:  P Alonso-Coello; Q Zhou; M J Martinez-Zapata; E Mills; D Heels-Ansdell; J F Johanson; G Guyatt
Journal:  Br J Surg       Date:  2006-08       Impact factor: 6.939

4.  Five-year treatment of chronic venous insufficiency with O-(β-hydroxyethyl)-rutosides: safety aspects.

Authors:  S Stuard; Maria Rosaria Cesarone; Gianni Belcaro; Mark Dugall; Andrea Ledda; Marisa Cacchio; Andrea Ricci; Edmondo Ippolito; Andrea Di Renzo; Maria Giovanna Grossi
Journal:  Int J Angiol       Date:  2008

5.  A randomised controlled trial of micronised purified flavonoid fraction vs placebo in patients with chronic venous disease.

Authors:  G Danielsson; C Jungbeck; K Peterson; L Norgren
Journal:  Eur J Vasc Endovasc Surg       Date:  2002-01       Impact factor: 7.069

Review 6.  Phlebotonics for haemorrhoids.

Authors:  Nirmal Perera; Danae Liolitsa; Satheesh Iype; Anna Croxford; Muhammed Yassin; Peter Lang; Obioha Ukaegbu; Christopher van Issum
Journal:  Cochrane Database Syst Rev       Date:  2012-08-15

7.  Micronized purified flavonidic fraction compared favorably with rubber band ligation and fiber alone in the management of bleeding hemorrhoids: randomized controlled trial.

Authors:  Y H Ho; M Tan; F Seow-Choen
Journal:  Dis Colon Rectum       Date:  2000-01       Impact factor: 4.585

Review 8.  A lymphatic function of Daflon 500 mg.

Authors:  C Labrid
Journal:  Int Angiol       Date:  1995-09       Impact factor: 2.789

Review 9.  Flavonoids. A review of the pharmacology and therapeutic efficacy of Daflon 500 mg in patients with chronic venous insufficiency and related disorders.

Authors:  J R Struckmann; A N Nicolaides
Journal:  Angiology       Date:  1994-06       Impact factor: 3.619

10.  Venoruton vs Daflon: evaluation of effects on quality of life in chronic venous insufficiency.

Authors:  M R Cesarone; G Belcaro; L Pellegrini; A Ledda; G Vinciguerra; A Ricci; A Di Renzo; I Ruffini; G Gizzi; E Ippolito; F Fano; M Dugall; G Acerbi; U Cornelli; M Hosoi; M Cacchio
Journal:  Angiology       Date:  2006 Mar-Apr       Impact factor: 3.619

View more
  5 in total

1.  Erratum to: Evaluation and management of hemorrhoids: Italian society of colorectal surgery (SICCR) consensus statement.

Authors:  M Trompetto; G Clerico; G F Cocorullo; P Giordano; F Marino; J Martellucci; G Milito; M Mistrangelo; C Ratto
Journal:  Tech Coloproctol       Date:  2016-03       Impact factor: 3.781

2.  The effect of diosmin against lead exposure in rats.

Authors:  Mehmet Bozdağ; Gökhan Eraslan
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2019-12-03       Impact factor: 3.000

3.  Flavonoid mixture (diosmin, troxerutin, rutin, hesperidin, quercetin) in the treatment of I-III degree hemorroidal disease: a double-blind multicenter prospective comparative study.

Authors:  Italo Corsale; Paolo Carrieri; Jacopo Martellucci; Alessandro Piccolomini; Luigi Verre; Marco Rigutini; Sonia Panicucci
Journal:  Int J Colorectal Dis       Date:  2018-06-22       Impact factor: 2.571

Review 4.  Management and Treatment of External Hemorrhoidal Thrombosis.

Authors:  Arcangelo Picciariello; Marcella Rinaldi; Ugo Grossi; Luigi Verre; Michele De Fazio; Agnese Dezi; Giovanni Tomasicchio; Donato F Altomare; Gaetano Gallo
Journal:  Front Surg       Date:  2022-05-03

5.  Determination of Diosmin in Pharmaceutical Products with Chemically Modified Voltammetric Sensors.

Authors:  Ramona Oana Gunache Roșca; Constantin Apetrei
Journal:  Int J Mol Sci       Date:  2021-07-07       Impact factor: 5.923

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.